Anti-LGI1 Encephalitis Clinical Trial
Official title:
Clinical, EEG and Radiological Initial and Evolutive Characterisation of LGI1-antibody Patients
Autoimmune encephalitis involve autoantibodies targeting central nervous system, and
particularly the synapse or its structure like for LGI1 protein. Anti-LGI1 encephalitis is
revealed by an inflammation of the limbic system, with mainly temporal lobe, faciobrachial
dystonic or generalized seizures, and cognitive disorders.
This disease is rare and its clinical, EEG and radiological characterisation is not
sufficiently established. The investigators will evaluate these three aspects for the
anti-LGI1 cohort of patients of the National Reference Center of autoimmune encephalitis.
n/a